EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Source: Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management ofrheumatoid arthritis with synthetic and biological disease- modifying antirheumatic drugs: 2022 update. Ann Rheum Dis Epub. Accessed on 28/06/025. doi:10.1136/ard-2022 223356

Overarching principles 10 recommendations on treating rheumatoid arthritis to target based on both evidence and expert opinion: